Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.8753
-0.0319 (-3.52%)
At close: Nov 13, 2026, 4:00 PM EST
0.8754
+0.0001 (0.01%)
After-hours: Nov 13, 2026, 7:30 PM EST
Immuron Market Cap
Immuron has a market cap or net worth of $8.13 million as of November 13, 2026. Its market cap has decreased by 14.37% in one year.
Market Cap
8.13M
Enterprise Value
2.12M
1-Year Change
-14.37%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $8.13M, a decrease of -71.05%. That is a compound annual growth rate of -12.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 7.30M | 62.22% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 8.78M |
| Vistagen Therapeutics | 8.13M |
| Moleculin Biotech | 7.85M |
| CollPlant Biotechnologies | 7.38M |
| GT Biopharma | 7.15M |
| Theriva Biologics | 7.08M |
| Exicure | 7.07M |
| Ensysce Biosciences | 7.00M |